GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apellis Pharmaceuticals Inc (STU:1JK) » Definitions » Balance Sheet Cash And Cash Equivalents

Apellis Pharmaceuticals (STU:1JK) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2023. Start your Free Trial

What is Apellis Pharmaceuticals Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


Apellis Pharmaceuticals Business Description

Industry
Traded in Other Exchanges
Address
100 Fifth Avenue, Waltham, MA, USA, 02451
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.